Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease

互联网2014-02-13

378

Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).

相关产品推荐

omcA/omcA蛋白/(Small-CRP)(9 kDa cysteine-rich lipoprotein)(9KD-CRP)蛋白/Recombinant Chlamydophila psittaci Small cysteine-rich outer membrane protein omcA (omcA)重组蛋白

￥69

GST pull-down试剂盒|GST 蛋白相互作用 Pull-Down 试剂盒|高效纯化/灵敏度高/特异性强| GST pull-down kit| GST Protein Interaction Pull-Down Kit

￥379

Svs4/Svs4蛋白/(Seminal vesicle protein 2)(Seminal vesicle secretory protein IV)(SVS IV)蛋白/Recombinant Mouse Seminal vesicle secretory protein 4 (Svs4)重组蛋白

￥69

F13L/F13L蛋白/(37 kDa protein)(Envelope protein F13)(Palmitoylated EV membrane protein)(p37K)蛋白/Recombinant Vaccinia virus Envelope phospholipase F13 (F13L)重组蛋白

￥69

ompA/ompA蛋白/Major outer membrane porin, serovar D(MOMP)蛋白/Recombinant Chlamydia trachomatis Major outer membrane porin, serovar D (ompA)重组蛋白

￥69